or Try an Advanced Search...

    Treatment Of Hypertension Stocks List

    Symbol Grade Name % Change
    MLYS C Mineralys Therapeutics, Inc. -1.14
    RDHL F Redhill Biopharma Ltd. -1.89
    BMY F Bristol-Myers Squibb Company -0.18
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Biopharmaceutical Hypertension Medicine Abdominal Pain Antibiotics Atrial Fibrillation Autoimmune Disease Bacteria Biopharmaceutical Products Cancer Treatment Cardiovascular Disease Chronic Myeloid Leukemia Clinic Clinical Medicine Crohn's Disease Depressive Disorder Diabetes Diabetic Nephropathy Dysfunction Dystrophy

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Hypertension stocks.

    Symbol Grade Name Weight
    FTXH B First Trust Nasdaq Pharmaceuticals ETF 6.37
    MEDX D Horizon Kinetics Medical ETF 4.71
    WBIY B WBI Power Factor High Dividend ETF 4.34
    IHE C iShares U.S. Pharmaceutical ETF 3.93
    XPH D SPDR S&P Pharmaceuticals ETF 3.86
    View all Treatment Of Hypertension ETFs...
    Compare ETFs
    Compare IHE to XPH Compare WBIY to IHE Compare WBIY to XPH

        Treatment Of Hypertension Stocks Recent News

        Date Stock Title
        May 17 BMY AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
        May 17 BMY The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
        May 17 BMY Erasca restructures; Novartis moves to complete MorphoSys deal
        May 17 BMY BMS reports four-year data from psoriasis treatment extension trial
        May 16 BMY Walmart Earnings & the State of the Consumer
        May 16 BMY Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
        May 16 BMY New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis
        May 16 BMY Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
        May 16 BMY FDA approves Bristol Myers Squibb’s Breyanzi for follicular lymphoma
        May 16 BMY Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
        May 15 BMY Bristol-Myers Squibb Company (BMY) Bank of America Global Healthcare Conference 2024 Transcript
        May 15 BMY Tudor Investment's top buys and sells in Q1
        May 15 BMY Bristol Myers' Breyanzi gains additional indication for follicular lymphoma
        May 15 BMY UPDATE 3-US FDA approves expanded use of Bristol Myers' cancer cell therapy
        May 13 BMY Bristol-Myers Squibb Company (BMY) Presents at Guggenheim Securities Radiopharmaceuticals Day (Transcript)
        May 13 BMY One stock is dragging down the S&P 500's earnings growth
        May 13 MLYS Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2024 Earnings Call Transcript
        May 13 BMY BMS and Zai Lab’s Augtyro gains NMPA approval to treat NSCLC
        May 13 BMY Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
        May 13 BMY These Stocks Are Moving the Most Today: GameStop, AMC, Arm, Squarespace, Tesla, Intel, Apple, Incyte, and More
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Biopharmaceutical Hypertension Medicine Abdominal Pain Antibiotics Atrial Fibrillation Autoimmune Disease Bacteria Biopharmaceutical Products Cancer Treatment Cardiovascular Disease Chronic Myeloid Leukemia Clinic Clinical Medicine Crohn's Disease Depressive Disorder Diabetes Diabetic Nephropathy Dysfunction Dystrophy
        Treatment Of Hypertension

        Treatment of hypertension typically involves lifestyle modifications such as reducing salt intake, increasing physical activity, and following a healthy diet. In addition, medications such as diuretics, beta-blockers, ACE inhibitors, and calcium channel blockers may be prescribed to help lower blood pressure.

        Browse All Tags